M. Richter

发表

Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site

T. Marlovits, N. Goessweiner-Mohr, J. Wald, 2019, Proceedings of the National Academy of Sciences.

Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses

V. Makarov, O. Riabova, J. Kirchmair, 2015, ChemMedChem.

Antipneumococcal activity of neuraminidase inhibiting artocarpin.

J. Rollinger, H. Saluz, K. Liedl, 2015, International journal of medical microbiology : IJMM.

Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.

M. Schmidtke, P. Wutzler, M. Richter, 2009, Antiviral research.

The Twenty-Third International Conference on Antiviral Research

X. Chen, Y. Pommier, D. Smee, 2010, Antiviral Research.

New insights into the anti-influenza activity of licorice constituents

J. Rollinger, K. Liedl, J. Kirchmair, 2013 .

Computer-Guided Approach to Access the Anti-influenza Activity of Licorice Constituents

J. Rollinger, K. Liedl, J. Kirchmair, 2013, Journal of natural products.

Discovery and Characterization of Diazenylaryl Sulfonic Acids as Inhibitors of Viral and Bacterial Neuraminidases

Christina E. Mair, J. Rollinger, K. Liedl, 2017, Front. Microbiol..

Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors

J. Rollinger, K. Liedl, J. Kirchmair, 2015 .

Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus

J. Rollinger, H. Saluz, J. Kirchmair, 2016, Front. Microbiol..

Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae

J. Rollinger, V. Makarov, J. Kirchmair, 2016, Scientific Reports.

Pyrrolo[2,3-e]indazole as a novel chemotype for both influenza A virus and pneumococcal neuraminidase inhibitors

M. Khrenova, M. Schmidtke, A. Egorova, 2023, RSC advances.

Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistance.

O. Riabova, A. Egorova, Elena Kazakova, 2024, Antiviral Research.